Newsroom

Sorted by: Latest

-

Resumen: STOKR obtiene las licencias CASP y PI en Luxemburgo antes de la aplicación de MiCAR

LUXEMBURGO--(BUSINESS WIRE)--STOKR, la plataforma luxemburguesa de valores digitales, ha recibido la autorización de la Commission de Surveillance du Secteur Financier (CSSF) en virtud del Reglamento de la Unión Europea relativo a los mercados de criptoactivos (MiCAR) y de la Ley de 10 de noviembre de 2009 sobre servicios de pago. Esta autorización le permite obtener las licencias como proveedor de servicios de criptoactivos (CASP) y entidad de pago (PI), apenas una semana antes de la aplicació...
-

Resumen: Heng Yi®, de Hengrui, ha sido autorizado en China como una innovadora solución oftálmica a base de ciclosporina para el tratamiento del síndrome del ojo seco

SHANGHÁI, HEIDELBERG (Alemania) y CAMBRIDGE (Massachusetts)--(BUSINESS WIRE)--Hengrui Pharma, una empresa farmacéutica internacional centrada en la innovación científica y tecnológica, y Novaliq GmbH («Novaliq»), una empresa biofarmacéutica especializada en tratamientos oftalmológicos pioneros y líderes en su clase basados en su exclusiva tecnología de plataforma sin agua EyeSol®, anuncian hoy que, el 23 de junio de 2026, la Administración nacional de productos médicos de China (NMPA) ha aproba...
-

Riassunto: Heng Yi® di Hengrui è stata approvata in Cina come soluzione oftalmica innovativa di ciclosporina per il trattamento della malattia dell'occhio secco

SHANGHAI e HEIDELBERG, Germania e CAMBRIDGE, Massachusetts--(BUSINESS WIRE)--Hengrui Pharma, un'azienda farmaceutica globale che si concentra sull'innovazione scientifica e tecnologica, e Novaliq GmbH (“Novaliq”), un'azienda biofarmaceutica che si concentra su terapie oculari innovative e di altissimo livello basate sulla sua esclusiva piattaforma con tecnologia senz'acqua EyeSol®, hanno annunciato oggi, 23 giugno 2026, che la China National Medical Products Administration (NMPA) ha approvato H...
-

Le produit Heng Yi® de Hengrui obtient l’autorisation de mise sur le marché en Chine en tant que solution ophtalmique innovante à base de cyclosporine pour le traitement de la sécheresse oculaire

SHANGHAI et HEIDELBERG, Allemagne et CAMBRIDGE, Massachusetts--(BUSINESS WIRE)--Hengrui Pharma, une société pharmaceutique mondiale axée sur l’innovation scientifique et technologique, et Novaliq GmbH (« Novaliq »), une société biopharmaceutique spécialisée dans les traitements ophtalmiques de première génération et de référence, basés sur sa technologie exclusive EyeSol® sans eau, annoncent aujourd’hui que le 23 juin 2026, l’Administration nationale chinoise des produits médicaux (NMPA) a appr...
-

Oconee Federal Financial Corp. Announces Board and Leadership Transition

SENECA, S.C.--(BUSINESS WIRE)--Oconee Federal Financial Corp. (OTCQX: OFED) (the “Company”), the holding company for Oconee Federal Savings and Loan Association (“Oconee Federal”), today announced leadership actions approved by the Boards of Directors of the Company and Oconee Federal on June 25, 2026. Curtis T. Evatt has been elected Chairman of the Boards of Directors of both the Company and Oconee Federal. Mr. Evatt will continue to serve as Chief Executive Officer of Oconee Federal and Pres...
-

Hilton Announces Second Quarter 2026 Earnings Release Date

MCLEAN, Va.--(BUSINESS WIRE)--Hilton Worldwide Holdings Inc. (NYSE: HLT) will report second quarter 2026 financial results before the stock market opens on Tuesday, July 28, 2026, followed by a conference call at 9 a.m. EDT. Christopher J. Nassetta, president & chief executive officer, Hilton, and Kevin Jacobs, executive vice president & chief financial officer, Hilton, will discuss the company's performance and lead a question-and-answer session. Participants may listen to the live web...
-

The New Germany Fund, Inc. Announces Results of the Fund’s Annual Meeting of Stockholders

NEW YORK--(BUSINESS WIRE)--The New Germany Fund, Inc. (NYSE: GF) (the “Fund”) announced today the results of its Annual Meeting of Stockholders held on June 30, 2026. The Class II Director nominated by the Board of Directors, Mr. Bernhard Koepp, was elected to serve for a term of three years and until his successor is elected and qualifies. Stockholders also ratified the appointment of Ernst & Young LLP as the independent auditors for the Fund for its 2026 fiscal year. A copy of the portfol...
-

The Central and Eastern Europe Fund, Inc. Announces Results of the Fund’s Annual Meeting of Stockholders

NEW YORK--(BUSINESS WIRE)--The Central and Eastern Europe Fund, Inc. (NYSE: CEE) (the “Fund”) announced today the results of its Annual Meeting of Stockholders held on June 30, 2026. Both of the two Class II Directors nominated by the Board of Directors, Ms. Fiona Flannery and Mr. Bernhard Koepp, were elected to serve a term of three years and until her or his respective successor is elected and qualifies. Stockholders also ratified the appointment of Ernst & Young LLP as the independent au...
-

NUBURU prevede che il patrimonio netto superi in modo significativo i requisiti della NYSE American, sulla base di una valutazione preliminare al 31 maggio

DENVER--(BUSINESS WIRE)--NUBURU, Inc. (NYSE American: BURU), azienda di nuova generazione attiva nel settore della difesa e della sicurezza dotata di una piattaforma a doppio scopo integrata, oggi ha reso noto che, sulla base di dati contabili preliminari, non sottoposti a revisione contabile al 31 maggio 2026, la Società prevede che il suo patrimonio netto superi in modo significativo i 4,0 milioni di dollari di patrimonio netto richiesti dal regolamento della NYSE American relativo alla sogli...
-

Insurity Appoints Jatin Atre as Chief Executive Officer

HARTFORD, Conn.--(BUSINESS WIRE)--Insurity, one of the largest software providers to the property and casualty insurance industry, today announced the appointment of Jatin Atre as Chief Executive Officer. Atre succeeds Jeff Clarke, who will continue with Insurity as Executive Chairman. Insurity serves more than 500 carriers and MGAs, is trusted by 22 of the top 25 P&C carriers, and 7 of the top 10 MGAs in the United States. The company enters this transition following its strongest new-logo...